Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Blanquart

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|June 25, 2005
Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transferChristophe Blanquart, Nicolas Boute, Danièle Lacasa, et al.
Oncotarget|November 1, 2014
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesotheliomaIza Denis, Laurent Cellerin, Marc Gregoire, et al.
International Journal of Molecular Sciences|August 23, 2020
Critical Roles of Tumor Extracellular Vesicles in the Microenvironment of Thoracic CancersLyna Kara-Terki, Lucas Treps, Christophe Blanquart, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammationChristophe Blanquart, Olivier Barbier, Jean Charles Fruchart, et al.
The Journal of Biological Chemistry|July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genesChristophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications|June 5, 2004
Different ways to regulate the PPARalpha stabilityChristophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Frontiers in Immunology|July 19, 2021
Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic OpportunitiesMargot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
International Journal for Numerical Methods in Biomedical Engineering|March 28, 2022
Influence of the mechanical and geometrical parameters on the cellular uptake of nanoparticles: A stochastic approachSarah Iaquinta, Shahram Khazaie, Éléna Ishow, et al.
Molecular Oncology|January 15, 2013
HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expressionPierre-François Cartron, Christophe Blanquart, Eric Hervouet, et al.
Molecular Endocrinology (Baltimore, Md.)|May 8, 2004
The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alphaChristophe Blanquart, Roxane Mansouri, Réjane Paumelle, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|June 25, 2005
Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transferChristophe Blanquart, Nicolas Boute, Danièle Lacasa, et al.
Oncotarget|November 1, 2014
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesotheliomaIza Denis, Laurent Cellerin, Marc Gregoire, et al.
International Journal of Molecular Sciences|August 23, 2020
Critical Roles of Tumor Extracellular Vesicles in the Microenvironment of Thoracic CancersLyna Kara-Terki, Lucas Treps, Christophe Blanquart, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammationChristophe Blanquart, Olivier Barbier, Jean Charles Fruchart, et al.
The Journal of Biological Chemistry|July 16, 2002
Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genesChristophe Blanquart, Olivier Barbier, Jean-Charles Fruchart, et al.
Biochemical and Biophysical Research Communications|June 5, 2004
Different ways to regulate the PPARalpha stabilityChristophe Blanquart, Roxane Mansouri, Jean-Charles Fruchart, et al.
Frontiers in Immunology|July 19, 2021
Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic OpportunitiesMargot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
International Journal for Numerical Methods in Biomedical Engineering|March 28, 2022
Influence of the mechanical and geometrical parameters on the cellular uptake of nanoparticles: A stochastic approachSarah Iaquinta, Shahram Khazaie, Éléna Ishow, et al.
Molecular Oncology|January 15, 2013
HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expressionPierre-François Cartron, Christophe Blanquart, Eric Hervouet, et al.
Molecular Endocrinology (Baltimore, Md.)|May 8, 2004
The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alphaChristophe Blanquart, Roxane Mansouri, Réjane Paumelle, et al.
Pageof 8